Yahoo
    NasdaqGM - Delayed Quote USD

    Prenetics Global Limited (PRE)

    17.76 -1.22 (-6.43%)
    At close: October 30 at 4:00:00 PM EDT
    Trade PRE on Coinbase
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for PRE
    • Previous Close 18.98
    • Open 18.75
    • Bid 13.72 x 200
    • Ask 23.43 x 200
    • Day's Range 17.30 - 18.84
    • 52 Week Range 11.36 - 27.24
    • Volume 101,826
    • Avg. Volume 211,581
    • Market Cap (intraday) 346.573M
    • Beta (5Y Monthly) 0.35
    • PE Ratio (TTM) --
    • EPS (TTM) -3.10
    • Earnings Date (est.) Nov 10, 2026
    • Forward Dividend & Yield -- (0.00%)
    • 1y Target Est 38.44
    • Motley Fool Rating Bearish

    Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

    www.prenetics.com

    98

    Full Time Employees

    December 31

    Fiscal Year Ends

    Consumer Defensive

    Sector

    Packaged Foods

    Industry

    More about Prenetics Global Limited

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

    YTD Return

    PRE
    12.76%
    S&P 500 (^GSPC)
    10.73%

    1-Year Return

    PRE
    25.51%
    S&P 500 (^GSPC)
    11.11%

    3-Year Return

    PRE
    238.29%
    S&P 500 (^GSPC)
    81.91%

    5-Year Return

    PRE
    84.51%
    S&P 500 (^GSPC)
    64.59%

    Earnings Trends

    View More

    Earnings Per Share

    GAAP
    Normalized
    GAAP
    Normalized

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q2 FY26
    Revenue 46.49M
    Earnings -8.98M
    Profit Margin -19.32%

    Q3

    FY25

    Q4

    FY25

    Q1

    FY26

    Q2

    FY26

    -20M
    0
    20M
    40M
    -60.0%
    -40.0%
    -20.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    30.00
    38.44 Average
    17.76 Current
    54.00 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell

    Latest Rating

    Date 10/26/2026
    Analyst Maxim Group
    Rating Action Initiated
    Rating Buy
    Price Action Announces
    Price Target 41
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      -30.40%

    • Return on Assets (ttm)

      -18.95%

    • Return on Equity (ttm)

      -47.01%

    • Revenue (ttm)

      154.59M

    • Net Income Avi to Common (ttm)

      -55.98M

    • Diluted EPS (ttm)

      -3.10

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      128.56M

    • Total Debt/Equity (mrq)

      0.73%

    • Levered Free Cash Flow (ttm)

      -36.15M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    RNR RenaissanceRe Holdings Ltd.
    339.32 +0.19%
    AXS AXIS Capital Holdings Limited
    104.87 +1.97%
    CNA CNA Financial Corporation
    48.68 -0.39%
    ACGL Arch Capital Group Ltd.
    106.36 +2.33%
    HCC Warrior Met Coal, Inc.
    85.97 +0.41%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: